The Safety and Efficacy of SYD-101 in Children With Myopia
Public ClinicalTrials.gov record NCT03918915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-masked, Vehicle-controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the Treatment of Myopia in Children
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Myopia, or nearsightedness, is the most common eye disorder, often affecting more than 40% of adults in Europe, Asia and the USA. Severe myopia is associated with an increased risk of developing other eye conditions such as glucoma, cataracts and retinal detachment, which may lead to blindness. Early treatment of myopia in children could help slow the condition and minimize the risk of complications later in life. This study investigates the use of SYD-101, an eye solution, in slowing-down the progression of myopia in children.
Study identification
- NCT ID
- NCT03918915
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 852 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Years to 14 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 24, 2019 (Actual)
- Primary completion
- May 2, 2024 (Actual)
- Completion
- May 1, 2025 (Actual)
- Last update posted
- Jul 30, 2026
2019 – 2025
United States locations
- U.S. sites
- 41
- U.S. states
- 22
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 143 | Irwindale | California | 91706 | — |
| Site 144 | Pasadena | California | 91105 | — |
| Site 148 | San Diego | California | 92127 | — |
| Site 104 | San Diego | California | 92131 | — |
| Site 110 | Santa Barbara | California | 93110 | — |
| Site 133 | Sunnyvale | California | 94087 | — |
| Site 130 | Colorado Springs | Colorado | 80920 | — |
| Site 100 | Fort Collins | Colorado | 80528 | — |
| Site 102 | Danbury | Connecticut | 06810 | — |
| Site 150 | Waterbury | Connecticut | 06708 | — |
| Site 122 | Fort Lauderdale | Florida | 33309 | — |
| Site 109 | Jupiter | Florida | 33477 | — |
| Site 119 | Sweetwater | Florida | 33182 | — |
| Site 120 | Tamarac | Florida | 33321 | — |
| Site 124 | Marietta | Georgia | 30060 | — |
| Site 116 | Chicago | Illinois | 60616 | — |
| Site 106 | Wilmette | Illinois | 60091 | — |
| Site 135 | Indianapolis | Indiana | 46202 | — |
| Site 131 | Munster | Indiana | 46321 | — |
| Site 137 | Pittsburg | Kansas | 66762 | — |
| Site 138 | Bangor | Maine | 04401 | — |
| Site 123 | Boston | Massachusetts | 02111 | — |
| Site 114 | Washington | Missouri | 63090 | — |
| Site 132 | Henderson | Nevada | 89052 | — |
| Site 139 | Albuquerque | New Mexico | 87109 | — |
| Site 127 | Buffalo | New York | 14209 | — |
| Site 117 | Chapel Hill | North Carolina | 27517 | — |
| Site 121 | Raleigh | North Carolina | 27603 | — |
| Site 105 | Fargo | North Dakota | 58103 | — |
| Site 111 | Medford | Oregon | 97504 | — |
| Site 147 | Tigard | Oregon | 97223 | — |
| Sie 136 | Bala-Cynwyd | Pennsylvania | 19004-1108 | — |
| Site 128 | Cranberry Township | Pennsylvania | 16066 | — |
| Site 108 | Charleston | South Carolina | 29425 | — |
| Site 126 | Lakeway | Texas | 78734 | — |
| Site 142 | San Antonio | Texas | 78215 | — |
| Site 101 | San Antonio | Texas | 78240 | — |
| Site 115 | The Woodlands | Texas | 77380 | — |
| Site 149 | Ogden | Utah | 84403 | — |
| Site 140 | Ogden | Utah | 84405 | — |
| Site 113 | Virginia Beach | Virginia | 23452 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03918915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03918915 live on ClinicalTrials.gov.